Golden Afternoon Clinic offers physician-supervised GLP-1 weight optimization therapy using high-quality compounded semaglutide and tirzepatide
The initial dose brings down out-of-pocket costs
Table of Contents Why GLP-1 Medications Cause Bloating Glucagon-like peptide-1 (GLP-1) receptor agonists including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Saxenda, Victoza) are increasingly prescribed for type 2 diabetes management and weight loss
GLP-1 receptor agonists are medications designed to mimic a naturally occurring hormone in the body that helps regulate appetite, digestion, blood sugar, and feelings of fullness
Also, in elderly diabetic patients with obesity, semaglutide therapy led to a moderate but clinically relevant reduction in BW and BMI after 3 months
The significant appetite suppression caused by tirzepatide often leads to reduced caloric intake, which is therapeutic for weight loss but may result in insufficient energy consumption for some patients